Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995629 · ClinicalTrials.gov registry record · NA
Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02995629 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 40 participants.
The verdict
NCT02995629, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Our aim is to compare patient comfort when using the 532 nanometer (green) wavelength laser to the 577 nanometer (yellow) wavelength laser during pan retinal photocoagulation to treat patients with diabetic retinopathy. Secondary outcome measures will be power (mW) required to achieve gray-white retinal burns and duration of treatment.
Interventions
- PROCEDURE laser indirect ophthalmoscopy pan retinal photocoagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02995629
The ClinicalTrials.gov registry entry for NCT02995629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laser indirect ophthalmoscopy pan retinal photocoagulation is the first listed.
NCT02995629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02995629 about?
NCT02995629 is a clinical study titled "Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation". Our aim is to compare patient comfort when using the 532 nanometer (green) wavelength laser to the 577 nanometer (yellow) wavelength laser during pan retinal photocoagulation to treat patients with diabetic retinopathy. Secondary outcome measures will be power (mW) required to achieve gray-white ret...
What is the current status of trial NCT02995629?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-03. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02995629?
The interventions under investigation include: laser indirect ophthalmoscopy pan retinal photocoagulation (PROCEDURE).
Who is sponsoring clinical trial NCT02995629?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.